| Patents for C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718) |
|---|
| 10/25/2006 | EP1289991B1 Method for inactivation of microorganisms using photosensitizers |
| 10/19/2006 | US20060235019 Substituted quinazolinone compounds |
| 10/11/2006 | CN1279177C Process for producing riboflavin |
| 10/10/2006 | US7119204 phenanthroline compounds that exhibit electroluminescence, photoluminescence and/or photosensitivity, used in electrical apparatus such as organic light emitting diodes |
| 10/05/2006 | US20060223836 New phenylalanine derivatives |
| 10/05/2006 | US20060223784 Method and compositions for temporarily incapacitating subjects |
| 10/05/2006 | CA2602546A1 Novel compounds |
| 10/03/2006 | US7115744 Method for producing 8-methoxy-quinolinecarboxylic acids |
| 10/03/2006 | US7115739 Triazole compounds useful as protein kinase inhibitors |
| 09/28/2006 | WO2006101845A2 Synthesis and purification of pteroic acid and conjugates thereof |
| 09/27/2006 | EP1173222B1 Conjugate having a cleavable linkage for use in a liposome |
| 09/27/2006 | EP0983765B1 Preventives or remedies for diseases in association with vascular functional anomaly relating to insulin resistance |
| 09/21/2006 | US20060211702 protein kinase inhibitors used for the treatment of cancers and/or prophylaxis of disorders associated with neurodegeneration resulting from ischemia, cardiac arrest, stroke and multi-infarct dementia |
| 09/20/2006 | EP1701957A1 2-amino-o4-substituted pteridines and their use as inactivators of o6-alkylguanine-dna alkyltransferase |
| 09/13/2006 | EP1699793A1 4-amino-7,8-dihydropteridines, pharmaceutical compositions containing them and their use for the treatment of diseases which are caused by an increased nitric oxide level |
| 09/06/2006 | EP1698627A1 Pyrazole compounds useful as protein kinase inhibitors |
| 08/31/2006 | WO2006090848A1 Method for detection of nucleotide polymorphism in gene used for diagnosing effect of methotrexate therapy in rheumatoid arthritis patient |
| 08/31/2006 | US20060194805 Capsaicin receptor agonists |
| 08/31/2006 | CA2614223A1 A registry method and control system for dea schedule ii-v medicines |
| 08/30/2006 | EP1695975A1 Stable crystalline salts of 5-methyltetrahydrofolic acid |
| 08/30/2006 | CN1826342A Process for the purification of riboflavin |
| 08/30/2006 | CN1826331A Pi-3 kinase inhibitor prodrugs |
| 08/29/2006 | US7098330 Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors |
| 08/24/2006 | US20060189620 Immunosuppressive effects of pteridine derivatives |
| 08/22/2006 | CA2118792C Immunopotentiating and infection protective agent and production thereof |
| 08/17/2006 | WO2006058669A3 Aminotetrahydropteridines and processes for the manufacture thereof |
| 08/09/2006 | EP1687308A2 Crystalline forms of (6r) -l-erythro-tetrahydrobiopterin dihydrochloride |
| 08/09/2006 | EP1687002A1 Fused heterocyclic compounds |
| 08/08/2006 | CA2282183C Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines |
| 08/08/2006 | CA2240571C The use of tetrahydrofolates in natural stereoisomeric form for the production of a pharmaceutical preparation suitable for influencing the homocysteine level, particularly for assisting the remethylation of homocysteine |
| 08/06/2006 | WO2006058869A2 Substituted pteridines for treating inflammatory diseases |
| 08/06/2006 | CA2587269A1 Substituted pteridines for treating inflammatory diseases |
| 08/03/2006 | WO2006058868A3 Substituted pteridines for treating inflammatory diseases |
| 08/02/2006 | EP1685840A2 Use of tetrahydrofolates for modulating the homocysteine level |
| 07/19/2006 | EP1680420A2 Compounds, compositions, and methods |
| 07/19/2006 | EP1478647B1 (6s)-5,6,7,8-tetrahydrofolic acid production process |
| 07/19/2006 | CN1264842C Method for producing by stereospecific hydration tetrahydropterins and optical pure derivatives, in particular tetrahydrofolic acid and its optically pure derivatives |
| 07/12/2006 | EP1678149A2 4-amino(aza)quinoline derivatives as capsaicin receptor agonists |
| 07/12/2006 | EP1427730B1 Novel dihydropteridinones, method for producing the same and the use thereof as medicaments |
| 07/12/2006 | CN1800182A N2-arylformyl-4-ammonia/amidopteridine analog compound capable of regulating nitrous oxide synthase acitivity |
| 07/11/2006 | US7074929 Certain alkylene diamine-substituted heterocycles |
| 07/11/2006 | US7074534 Polymeric charge transport compositions and electronic devices made with such compositions |
| 07/11/2006 | CA2260999C Heterocyclic compounds, their production and use in tyrosine kinase inhibition |
| 07/06/2006 | WO2006070902A1 Method for producing l-biopterin |
| 07/06/2006 | CA2594320A1 Method for producing l-biopterin |
| 07/05/2006 | EP1675862A1 New 2-substituted, 4-amino-thiazolo 4,5-d pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1 |
| 07/04/2006 | US7071193 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases |
| 07/04/2006 | CA2332066C Tetrazole compounds as thyroid receptor ligands |
| 06/29/2006 | US20060142573 Method for producing L-biopterin |
| 06/28/2006 | EP1673092A1 Heterocycle-substituted pteridine derivatives and their use in therapy |
| 06/27/2006 | US7067659 allopurinol, oxypurinol, or pterin-6-aldehyde derivatives containing one or more nitrate groups, used for heart failure and stable angina |
| 06/27/2006 | US7067658 Anxiolytic agents; antidepressants; Alzheimer, Huntington, Parkinson disease |
| 06/22/2006 | WO2006065703A1 Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors |
| 06/22/2006 | CA2590294A1 Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors |
| 06/21/2006 | EP1670799A1 Process for the purification of riboflavin |
| 06/20/2006 | CA2121523C Sulfonamide derivatives |
| 06/15/2006 | WO2006018222A8 Hydrates and polymorphs of 4-[[(7r)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-4-6-oxo-2-piperidinyl]amino]-3-methoxy-n-(1-methyl-4-piperidinyl) benzamide, methods for the production thereof, and use thereof as medicaments |
| 06/15/2006 | US20060128749 Compounds |
| 06/14/2006 | EP1669355A1 Aminotetrahydropteridines and processes for manufacture thereof |
| 06/14/2006 | DE102004058337A1 Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten Process for the preparation of fused Piperazine-2-one derivatives |
| 06/08/2006 | WO2006058876A1 Method for producing annelated piperazin-2-one derivatives and intermediates of said method |
| 06/08/2006 | WO2006058868A2 Substituted pteridines for treating inflammatory diseases |
| 06/08/2006 | WO2006058867A2 Substituted pteridines for the treatment of inflammatory diseases |
| 06/08/2006 | US20060122393 Process for the manufacture of fused piperazin-2-one derivatives |
| 06/08/2006 | US20060122096 Reversible modification of amine-containing compounds |
| 06/08/2006 | DE102004057595A1 Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen Substituted pteridines for the treatment of inflammatory diseases |
| 06/08/2006 | DE102004057594A1 Substitueirte Pteridine zur Behandlung von entzündlichen Erkrankungen Substitueirte pteridines for the treatment of inflammatory diseases |
| 06/08/2006 | CA2588857A1 Method for producing annelated piperazin-2-one derivatives and intermediates of said method |
| 06/08/2006 | CA2587266A1 Substituted pteridines for treating inflammatory diseases |
| 06/08/2006 | CA2587261A1 Substituted pteridines for the treatment of inflammatory diseases |
| 06/07/2006 | EP1663254A2 Anti-inflamatory phosphonate conjugates |
| 06/07/2006 | EP1663244A2 Pteridine derivatives for the treatment of septic shock and tnf-alpha-related diseases. |
| 06/07/2006 | CN1781919A Method for producing by stereospecific hydration tetrahydropterins and optically pure derivatives, in particular tetrahydrofolic acid and its optically pure derivatives |
| 06/06/2006 | US7056911 for example, N-[(2,4-diaminopteridin-6-yl)methyl]-9,10-dihydrodibenz[b,f]azepine; may be useful for treatment or prophylaxis of diseases associated with parasitic infection such as pneumocystis pneumonia, toxoplasmosis, cryptosporidiosis, leischmaniasis and malaria |
| 06/01/2006 | WO2006056607A1 Substituted pteridines for treating inflammatory diseases |
| 06/01/2006 | WO2006014706A3 Methotrexate derivatives useful for treating cancer and arthritis |
| 06/01/2006 | US20060116373 Substituted pteridines for the treatment of inflammatory diseases |
| 06/01/2006 | US20060116372 Substituted pteridines for the treatment of inflammatory diseases |
| 06/01/2006 | US20060116371 4-Substituted with a 1-pyrrolyl-, 1-piperidinyl- or 4-piperidinyl ring, e.g., lbenzyl-(6-methoxy-2-piperazin-1-yl-4-pyrrolidin-1-yl-pteridin-7-yl)-amine; phosphodiesterase inhibitors with reduced side effects, particularly nausea; respiratory, gastrointestinal, skin, joint, and eye disorders, cancer |
| 06/01/2006 | US20060116370 Substituted pteridines for the treatment of inflammatory diseases |
| 06/01/2006 | DE102004057645A1 New substituted pteridine compounds, useful as phosphodiesterase 4 inhibitors for treating e.g. inflammatory diseases, cancer, asthma, ulcerative colitis, depression and schizophrenia |
| 06/01/2006 | DE102004057618A1 Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen Substituted pteridines for the treatment of inflammatory diseases |
| 06/01/2006 | CA2589209A1 Substituted pteridines for treating inflammatory diseases |
| 05/31/2006 | EP1318997B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317449B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317444B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/30/2006 | US7053089 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate (NMDA) |
| 05/30/2006 | CA2321380C 6-azauracil derivatives as thyroid receptor ligands |
| 05/25/2006 | US20060111374 N-(3-amino-propyl)-N-[1-(3-benzyl-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl)-2-methyl-propyl]-4-methyl-benzamide; kinesin spindle protein inhibitor; cell division, mitosis phase arrest; antiproliferative and antiinflammation agent, hyperplasias, restenosis, cardiac hypertrophy, autoimmune disorders |
| 05/24/2006 | EP1658081A2 Immunosuppressive effects of pteridine derivatives |
| 05/24/2006 | EP1373225B1 Process for coupling amino acids to an antifolate scaffold |
| 05/23/2006 | US7049326 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots |
| 05/18/2006 | US20060106256 e.g. 1-[(benzylamino)methyl]-3-(3,5-difluorophenyl)-2-({3-[(dipropylamino)carbonyl]benzoyl}amino)propyl 4-nitrophenyl carbonate; secretase inhibitors; neurodegenerative disorders; Alzheimer's, Parkinson's diseases, Down syndrom, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type |
| 05/17/2006 | EP1317452B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317447B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | CN1774438A Method for the production of riboflavin of modification B/C in granular form |
| 05/09/2006 | CA2233666C Heterocyclic fungicides |
| 05/03/2006 | EP1651229A1 Guanidino-substituted quinazolinone compounds as mc4-r agonists |
| 05/03/2006 | CN1765898A Method for preparing spherical crystal lactochrome utilizing solvent supersonic synergetic effect |
| 05/03/2006 | CN1765897A Lactochrome fermentation liquor extraction process |